Simplicity Wealth’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Sell
11,274
-6,646
-37% -$361K 0.02% 661
2026
Q1
$1.12M Buy
17,920
+290
+2% +$23.2K 0.06% 273
2025
Q4
$1.68M Sell
17,630
-700
-4% -$68.6K 0.1% 196
2025
Q3
$1.79M Sell
18,330
-21,884
-54% -$2.27M 0.1% 203
2025
Q2
$4.32M Buy
40,214
+19,800
+97% +$2M 0.18% 126
2025
Q1
$2.06M Buy
+20,414
New +$2.06M 0.16% 149
2024
Q4
Sell
-6,138
Closed -$514K 356
2024
Q3
$514K Sell
6,138
-285,392
-98% -$22.5M 0.05% 287
2024
Q2
$22.5M Buy
291,530
+3,708
+1% +$271K 0.51% 34
2024
Q1
$19.7M Buy
+287,822
New +$18.5M 0.47% 34

Other funds holding BSX

Simplicity Wealth's BSX Position: Q2 2026 in Review

Simplicity Wealth reduced its Boston Scientific (BSX) stake by 37% in Q2 2026, selling an estimated $361K and leaving 11,274 shares worth $481K. The position accounts for 0.02% of the portfolio, ranked #661.

Simplicity Wealth first reported a position in BSX in Q1 2024 and has held it in 9 quarters since. The position peaked at $22.5M in Q2 2024. 844 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Simplicity Wealth held 11,274 shares of Boston Scientific worth $481K as of Q2 2026.
  • Simplicity Wealth sold 6,646 Boston Scientific shares in Q2 2026, an estimated $361K.
  • Boston Scientific made up 0.02% of Simplicity Wealth's portfolio in Q2 2026, its #661 holding.
  • Simplicity Wealth first reported a position in Boston Scientific in Q1 2024 and has held it in 9 quarters since.
  • Simplicity Wealth's Boston Scientific position peaked at $22.5M in Q2 2024.
  • 844 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.